Rhythm Control Strategies for Atrial Arrhythmias in Special Populations

Description

This scintillating session will describe the newest information/data on the safety and efficacy of various rhythm control strategies for atrial arrhythmias in special populations.

Learning Objectives

Describe the safety and efficacy of rhythm control strategies in women with atrial arrhythmias.
Compare the safety and efficacy of various rhythm control strategies in underrepresented racial and ethnic groups with atrial arrhythmias.
Outline the safety and efficacy of various rhythm control strategies in older populations (patients greater than 75 years of age) with atrial arrhythmias.

Session Chair(s)

Larry Jackson, MD, MHS
Patricia Tung, MD, MPH

Presentation

Rhythm Control Strategies for Atrial Arrhythmias in Elderly Patients (> 75 years of age): Should I Choose Antiarrhythmics or Catheter Ablation?
Presenter(s): Annabelle S. Volgman, MD

Is Catheter Ablation Preferred Over Antiarrhythmic Drug Therapy in Underrepresented Racial and Ethnic Groups with AF? A Battle of Different Rhythm Control Strategies
Presenter(s): Ijeoma Ekeruo, MD

Utilization and Outcomes of Rhythm Control Strategies for Atrial Arrhythmias in Women
Presenter(s): Andrea M. Russo, MD

Rhythm Control Strategies for Management of Atrial Fibrillation in Younger Patients
Presenter(s): Kelly Arps, MD

Disclosures

Annabelle Volgman:

Sanofi (Honoraria/Speaking/Consulting Fee - Consulting)
Pfizer, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Novartis (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Apple Inc. (Stocks – Publicly Traded - Investment)
Janssen Pharmaceuticals (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)

Ijeoma Ekeruo:

Sanofi (Honoraria/Speaking/Consulting Fee - Consulting)
Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)

Andrea Russo:

UpToDate, Inc. (Royalty Income - Writing/editing)
Pacemate (Honoraria/Speaking/Consulting Fee - Consulting)
AtriCure, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Bayer Healthcare Pharmaceuticals (Honoraria/Speaking/Consulting Fee - Consulting)
Boston Scientific (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Abbott Medical (Honoraria/Speaking/Consulting Fee - Consulting)
BMS / Pfizer Alliance (Honoraria/Speaking/Consulting Fee - Speaking)
Medtronic,Inc. (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Medtronic (Honoraria/Speaking/Consulting Fee - Consulting)
Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Boston Scientific (Honoraria/Speaking/Consulting Fee - Research Steering Committee/Consulting)
Biotronik (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Abbott (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Bayer Healthcare Pharmaceuticals (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Biotronik (Honoraria/Speaking/Consulting Fee - Consulting)
Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
Sanofi (Honoraria/Speaking/Consulting Fee - Consulting)

Kelly Arps:

Nothing Relevant to Disclose

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

Supraventricular Tachyarrhythmias
-- AFib and Flutter - Catheter Ablation
-- 152. Skill to perform pulmonary vein isolation and confirm entrance and exit block.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered